{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "CIP2A",
      "Cancer",
      "Oncoprotein",
      "PP2A",
      "c-Myc"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "29035828",
  "DateCompleted": {
    "Year": "2018",
    "Month": "07",
    "Day": "26"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "12",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2017",
        "Month": "10",
        "Day": "13"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.biopha.2017.08.146",
      "S0753-3322(17)34269-5"
    ],
    "Journal": {
      "ISSN": "1950-6007",
      "JournalIssue": {
        "Volume": "96",
        "PubDate": {
          "Year": "2017",
          "Month": "Dec"
        }
      },
      "Title": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie",
      "ISOAbbreviation": "Biomed Pharmacother"
    },
    "ArticleTitle": "The role of CIP2A in cancer: A review and update.",
    "Pagination": {
      "StartPage": "626",
      "EndPage": "633",
      "MedlinePgn": "626-633"
    },
    "Abstract": {
      "AbstractText": [
        "Cancerous inhibitor of protein phosphatase 2A (CIP2A) is a characterized human oncoprotein that is able to promote cancer cells proliferation, anchorage-independent cell growth and resistance to apoptosis. CIP2A inactivates protein phosphatase 2A (PP2A) which down-regulates Akt (Protein Kinase B) phosphorylation and stabilizes c-Myc (c-Myc oncogene product) in cancer cells. CIP2A has been studied in the most of human malignancies. Here we discuss the role of CIP2A in cancer and give a summary of CIP2A expression in malignancies. Also, where available we indicated the association of CIP2A with the stage of cancers and patients prognosis, explain its localization and the possibility of targeting CIP2A in different cancers."
      ],
      "CopyrightInformation": "Copyright \u00a9 2017 Elsevier Masson SAS. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Molecular Medicine, Faculty of Advanced Biomedical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran."
          }
        ],
        "LastName": "Soofiyani",
        "ForeName": "Saiedeh Razi",
        "Initials": "SR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Molecular Medicine, Faculty of Advanced Biomedical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran."
          }
        ],
        "LastName": "Hejazi",
        "ForeName": "Mohammad Saeid",
        "Initials": "MS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: baradaranb@tbzmed.ac.ir."
          }
        ],
        "LastName": "Baradaran",
        "ForeName": "Behzad",
        "Initials": "B"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "France",
    "MedlineTA": "Biomed Pharmacother",
    "NlmUniqueID": "8213295",
    "ISSNLinking": "0753-3322"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Autoantigens"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Biomarkers, Tumor"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "CIP2A protein, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Intracellular Signaling Peptides and Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Membrane Proteins"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Apoptosis"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Autoantigens"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Biomarkers, Tumor"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Line, Tumor"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Cell Proliferation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Intracellular Signaling Peptides and Proteins"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Membrane Proteins"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Signal Transduction"
    }
  ]
}